HSPG2 and diabetic cardiomyopathy: Additionally, diabetic cardiomyopathy is characterized by an increase in oxidative stress levels, and, considering the inhibitory effect of oxidants on PLC [68], it is possible that the reduction in PLCβ3 levels observed in diabetic cardiomyopathic conditions may be attributed to the induction of oxidative conditions.